Similar articles for PMID: 28731711

Year	Number of Results
1955	1
1962	1
1992	1
1997	1
1999	2
2000	2
2001	2
2002	1
2003	2
2004	5
2005	1
2006	5
2008	7
2009	10
2010	2
2011	10
2012	20
2013	13
2014	15
2015	20
2016	24
2017	29
2018	18
2019	15
2020	15
2021	5
2022	7
2023	1

1

Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.

Codreanu SG, Hoeksema MD, Slebos RJC, Zimmerman LJ, Rahman SMJ, Li M, Chen SC, Chen H, Eisenberg R, Liebler DC, Massion PP. Codreanu SG, et al. J Proteome Res. 2017 Sep 1;16(9):3266-3276. doi: 10.1021/acs.jproteome.7b00245. Epub 2017 Aug 8. J Proteome Res. 2017. PMID: 28731711 Free PMC article.

2

In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.

Kikuchi T, Hassanein M, Amann JM, Liu Q, Slebos RJ, Rahman SM, Kaufman JM, Zhang X, Hoeksema MD, Harris BK, Li M, Shyr Y, Gonzalez AL, Zimmerman LJ, Liebler DC, Massion PP, Carbone DP. Kikuchi T, et al. Mol Cell Proteomics. 2012 Oct;11(10):916-32. doi: 10.1074/mcp.M111.015370. Epub 2012 Jul 3. Mol Cell Proteomics. 2012. PMID: 22761400 Free PMC article.

3

[Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].

Luo XY, Chen HQ, Sun YH, Zhou JH, Wang WF, Liao P, Xiang CQ. Luo XY, et al. Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):907-10. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533741 Chinese.

4

Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.

Kahn N, Meister M, Eberhardt R, Muley T, Schnabel PA, Bender C, Johannes M, Keitel D, Sültmann H, Herth FJ, Kuner R. Kahn N, et al. J Thorac Oncol. 2012 Jun;7(6):1001-8. doi: 10.1097/JTO.0b013e31824fe921. J Thorac Oncol. 2012. PMID: 22588153 Free article.

5

Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.

Zhou X, Xue L, Hao L, Liu S, Zhou F, Xiong H, Qi X, Lin D, Shao S. Zhou X, et al. Biomed Pharmacother. 2013 Sep;67(7):621-7. doi: 10.1016/j.biopha.2013.06.005. Epub 2013 Jul 4. Biomed Pharmacother. 2013. PMID: 23916545

6

MicroRNA-144 regulates proliferation, invasion, and apoptosis of cells in malignant solitary pulmonary nodule via zinc finger E-box-binding homeobox 1.

Zhang G, An H, Fang X. Zhang G, et al. Int J Clin Exp Pathol. 2015 May 1;8(5):5960-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191328 Free PMC article.

7

[Omics technologies in diagnostics of lung adenocarcinoma].

Novikova SE, Kurbatov LK, Zavialova MG, Zgoda VG, Archakov AI. Novikova SE, et al. Biomed Khim. 2017 May;63(3):181-210. doi: 10.18097/PBMC20176303181. Biomed Khim. 2017. PMID: 28781253 Review. Russian.

8

MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6.

Han HS, Son SM, Yun J, Jo YN, Lee OJ. Han HS, et al. FEBS Lett. 2014 Oct 16;588(20):3744-50. doi: 10.1016/j.febslet.2014.08.023. Epub 2014 Aug 27. FEBS Lett. 2014. PMID: 25171863 Free article.

9

Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.

Li X, Zhang Q, Jin X, Cao L. Li X, et al. World J Surg Oncol. 2017 May 25;15(1):107. doi: 10.1186/s12957-017-1171-y. World J Surg Oncol. 2017. PMID: 28545454 Free PMC article.

10

Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.

Ha ES, Choi S, In KH, Lee SH, Lee EJ, Lee SY, Kim JH, Shin C, Shim JJ, Kang KH, Phark S, Sul D. Ha ES, et al. Clin Biochem. 2013 Mar;46(4-5):369-77. doi: 10.1016/j.clinbiochem.2012.11.014. Epub 2012 Nov 29. Clin Biochem. 2013. PMID: 23200884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed